Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SPCTR logo — Improving patient outcomes after cancer surgery

SPCTR

Improving patient outcomes after cancer surgery

Founded 2025 The Netherlands The Netherlands 7 employees AI, Health Care +1

General Information

Company Name SPCTR
Founded Year 2025
Location The Netherlands The Netherlands
Employees 7
Industries AI, Health Care, Medical Devices
Business Model B2B, B2D, B2B2B
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with SPCTR. To contact SPCTR, visit spctr.tech.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SPCTR compare?

A PDF of SPCTR and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SPCTR soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SPCTR

SPCTR, founded in 2025 and headquartered in The Netherlands, is at the forefront of revolutionizing post-cancer surgery care. With their slogan, “Improving patient outcomes after cancer surgery”, the company focuses on harnessing the power of light and artificial intelligence to enhance medical procedures.

This innovative startup lies at the intersection of AI, Health Care, and Medical Devices, showcasing significant potential to transform how surgeries are conducted globally. Specifically, SPCTR targets reducing patient stress, minimizing reoperations, and optimizing surgical efficiency, which in turn alleviates pressure on healthcare systems.

Having raised an Early VC investment from Future Tech Ventures on 01 February 2026, SPCTR is strategically positioned to further advance its technology and expand its market reach. This burgeoning company's novel approach may attract investors interested in pioneering ventures within the medical technology landscape.

Business keywords: Patient Outcomes, Cancer Surgery, Light Technology, Healthcare Efficiency, Stress Reduction, Reoperation Reduction, Surgical Technology, Oncology Solutions, MedTech Innovation, AI in Healthcare, Surgical Time Management

Services & Products

AI-powered real-time margin assessment
cancer surgery decision support

Target Customers

cancer surgeons oncology departments healthcare institutions health insurance companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC Undisclosed 1
Future Tech Ventures
01 Feb 2026

SPCTR Alternatives & Competitors

View All Alternatives
SPCTR vs
OncoRes Medical
OncoRes Medical Australia

Transforming the standard of care in breast cancer surgery.

42 employees
Biotechnology, Health Care
SPCTR vs
Noleus Technologies
Noleus Technologies United States

Accelerating patient recovery after surgery

Non Equity Assistance
6 employees
Health Care, Medical Devices
SPCTR vs
Prescient Surgical
Prescient Surgical United States

Lower risk. Better patient outcomes.

Grant
4 employees
Health Care, Medical Devices
View all alternatives

FAQ About SPCTR

Improving patient outcomes after cancer surgery
SPCTR was founded in 2025.
SPCTR is headquartered in The Netherlands.
SPCTR operates in AI, Health Care and Medical Devices. Its work centres on Patient Outcomes, Cancer Surgery, Light Technology and Healthcare Efficiency. Its customers include cancer surgeons, oncology departments and healthcare institutions.
SPCTR has a B2B, B2D and B2B2B business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
SPCTR has approximately 7 employees.
SPCTR has completed 1 funding round.
SPCTR offers: AI-powered real-time margin assessment, cancer surgery decision support.
Top alternatives and competitors to SPCTR include OncoRes Medical, Noleus Technologies, Prescient Surgical, Vision Surgery AI Inc., CMR Surgical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SPCTR and OncoRes Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SPCTR, https://bouncewatch.com/company/spctr, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes